Frank A. Petrigliano; Nancy Q. Liu; Siyoung Lee; Jade Tassey; Arijita Sarkar; Yucheng Lin; Liangliang Li; Yifan Yu; Dawei Geng; Jiankang Zhang; Ruzanna Shkhyan; Jacob Bogdanov; Ben Van Handel; Gabriel B. Ferguson; Youngjoo Lee; Svenja Hinderer; Kuo-Chang Tseng; Aaron Kavanaugh; J. Gage Crump; April D. Pyle; Katja Schenke-Layland; Fabrizio Billi; Liming Wang; Jay Lieberman; Mark Hurtig; Denis Evseenko
npj Regenerative Medicine. 2021;6(1):77.
https://doi.org/10.1038/s41536-021-00187-3
17 citations · 6 en 2025–2026
Les titres, résumés et légendes des publications sont présentés en anglais.
Editorial summary
This study develops an articular chondrocyte formulation derived from human embryonic stem cells and evaluates its capacity to repair cartilage in pigs. Cell identity, differentiation and manufacturing characteristics were assessed alongside long-term repair outcomes. The formulation was designed to support scaling and cryopreservation, and the resulting repair tissue was evaluated using biological and mechanical analyses. The findings support further development of an allogeneic cell-based approach to focal cartilage repair. Although the cells are human derived, the repair experiments described here were performed in a porcine preclinical model rather than in patients.
Utilisation des équipements
Note de référencement — Cartilage réparé porcin : cartographie par indentation et mesure d’épaisseur avec le Mach-1.
Matériaux (1)
